Patients are transforming from passive recipients of healthcare services to active participants in their own health
- For the first time, patients are transforming from passive recipients of healthcare services to active participants in their own health.
- They're flocking to online review sites to choose which doctor to see, skipping hospital visits in favor of a health clinic in their local CVS, and aren't afraid to ditch providers that don't offer them an engaging experience.
- The superior customer service expectations of millennials, declines in hospital profitability, and threats from startup providers and retail pharmacies intensify the need for providers to revamp the patient experience.
- Providers' current engagement capabilities are weak, and deficiencies around scheduling, appointment wait times, and billing are dragging on patient satisfaction, driving patients elsewhere and draining provider revenue.
- In The Healthcare Consumerization Report, Business Insider Intelligence explores the trends that are driving providers to revamp their care services.
BIG TECH IN HEALTHCARE: How Alphabet, Amazon, Apple, and Microsoft are shaking up healthcare — and what it means for the future of the industry
- The potential for tech-led digital health initiatives to help healthcare providers and insurers deliver safer, more efficient, and cost-effective care is significant.
- For healthcare organizations of all types, the collection, analyses, and application of patient data can minimize avoidable service use, improve health outcomes, and promote patient independence, which can assuage swelling costs.
- For their part, the "Big Four" tech companies — Google-parent Alphabet, Amazon, Apple, and Microsoft — see an opportunity to tap into the lucrative health market.
- In The Big Tech in Healthcare Report, Business Insider Intelligence explores the key strengths and offerings the Big Four will bring to the healthcare industry, as well as their approaches into the market.
- The companies included in this report are: Alphabet, Amazon, Apple, Microsoft, Facebook, FitBit, MyFitnessPal, Verily Life Sciences, Calico, DeepMind, Merck, Berkshire Hathaway, JPMorgan Chase, Retail Pharmaceuticals, PillPack, Aetna, UnitedHealthcare, John Hancock.
Scientists are teaching the body to accept new organs without anti-rejection drugs
- If it worked, he would receive a donated liver without needing to take powerful drugs to prevent the immune system from rejecting it.
- Most of the scientific research so far has focused on liver and kidney transplant patients for several reasons, says James Markmann, chief of the division of transplant surgery at Massachusetts General Hospital.
- The more researchers learned about the symphony of white blood cells that control responses to infections and cancers – and transplanted organs – the more they began to see hope for modifying the body's immune system.
- The process, scientists hope, will teach the immune system to accept the donated organ as part of the patient's body.
- Afterward, Schaffer was taking 40 pills a day to prevent infections and to tamp down his immune system while his body learned to accept the new organ.
A Silicon Valley company just launched 'smart' cancer pills that track you with tiny sensors stamped into your medications
- The Silicon Valley-based company makes what have been called "smart pills": essentially, versions of regular medications embedded with a tiny sensor that can be tracked by a patch worn on a patient's stomach.
- As part of the trial, seven patients with advanced colorectal cancer are now taking a sensor-embedded version of the common chemotherapy drug capecitabine in place of their regular medicine.
- Proteus' digital pills work by way of a tiny sensor roughly the size of a period.
- Scientists behind a clinical trial of roughly 50,000 patients published in JAMA Internal Medicine in 2017 concluded that none of three devices designed to remind patients to take their pills significantly improved medication adherence rates.
- It remains to be seen whether Proteus' digital cancer pills will help patients take their medications when they should.
Insulin Wars: How insurance companies farm out dirty work to doctors patients
- How insurance companies farm out their dirty work to doctors and patients.
- I’d prescribed her the insulin she’d been on, at the correct dosage, but when she showed up at her pharmacy she learned that her insurance company no longer covered that brand.
- All insurance companies periodically change which medications they cover, but insulin is in a whirlwind class by itself because of the staggering sums of money involved.
- It’s a colossal time-waster, as patients, pharmacists and doctors log hours upon hours calling, faxing, texting and emailing to keep up with whichever insulin is trending.
- It’s also dangerous, as patients can end up without a critical medication for days, sometimes weeks, waiting for these bureaucratic kinks to get ironed out.
- It suddenly struck me that insurance companies and drug manufacturers had come upon an ingenious business plan: They could farm out their dirty work to the doctors and the patients.
Google fined €50 million for GDPR violation in France
- France’s data protection regulator, CNIL, has issued Google a €50 million fine (around $56.8 million USD) for failing to comply with its GDPR obligations.
- This is the biggest GDPR fine yet to be issued by a European regulator and the first time one of the tech giants has been found to fall foul of the tough new regulations that came into force in May last year.
- CNIL said that the fine was issued because Google failed to provide enough information to users about its data consent policies and didn’t give them enough control over how their information is used.
- Responding to the fine, a Google spokesperson said that the company is “deeply committed” to meeting the “high standards of transparency and control” that people expect of it.
The VA Wants to Use DeepMind's AI to Prevent Kidney Disease
- In a project that drew on roughly 700,000 medical records from US veterans, the agency worked with Google parent Alphabet’s DeepMind unit to create software that attempts to predict which patients are likely to develop AKI.
- The company has a track record of breaking new ground in machine learning, including bots that beat Atari games and masters of the board game Go. Early in 2018, the VA announced that it had signed a formal research agreement with DeepMind.
- VA researchers and engineers developed a process that uses cryptographic hashes to obscure lab results and other data in a health record, Nielsen says.
- The agency’s rich data trove and the protocol it developed to scrub data before transferring it to DeepMind offer the potential to try and predict other health problems in hospital patients early, he says.
Three untapped opportunities wearables present to health insurers, providers, and employers
- In turn, insurers, providers, and employers are poised to become just as active leveraging these devices - and the data they capture - to abandon the traditional reimbursement model and improve patient outcomes with personalized, value-based care.
- A new report from Business Insider Intelligence, Business Insider's premium research service, follows the growing adoption of wearables and breadth of functions they offer to outline how healthcare organizations and stakeholders can overcome this challenge and add greater value with wearable technology.
- It explores the key drivers behind wearable usage by insurers, healthcare providers, and employers, and the opportunities wearables afford to each of these stakeholders.
- By outlining a successful case study from each stakeholder, the report highlights best practices in implementing wearables to reduce healthcare claims, improve patient outcomes, and drive insurance cost savings, as well as how the evolution of the market will create new, untapped opportunities for businesses.